Clinical trials: Schizophrenia Prodrome
Schizophrenia Prodrome
D-serine for the Schizophrenia Prodrome
The purpose of the study is to determine the safety and efficacy of D-serine as an early intervention treatment for the schizophrenia prodrome condition.
- Trial name
- NCT00826202
- Testing
- D-serine
- Where
- 4 sites in United States
- Volunteers
- 44 people
- Sponsor
- Nathan Kline Institute for Psychiatric Research
Patients at Ultra-high Risk of Psychosis
Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of Psychosis
Cognitive deficits are known to be a core feature of schizophrenia and seem to become manifest in the prodromal or Ultra-High Risk (UHR) state of psychosis.
- Trial name
- FOCUS (NCT02098408)
- Testing
- Cognitive remediation, Standard treatment
- Where
- Denmark
- Volunteers
- 146 people
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Prodromal Schizophrenia
Effects of NAC on Symptoms of CHR Patients
Schizophrenia is a chronic debilitating psychotic disorder. Identifying persons with "clinical high-risk" (CHR) symptoms, which are like those of schizophrenia but less severe, and providing psychiatric care to these individuals…
- Trial name
- NCT05142735
- Testing
- N-Acetylcysteine
- Where
- Canada
- Volunteers
- 90 people
- Sponsor
- Centre for Addiction and Mental Health
Psychotic Disorders
Dutch Prediction of Psychosis Study
The Dutch Prediction of Psychosis Study (DUPS) is a prospective study of predictors of the transition to psychosis in help-seeking adolescents at high risk for developing a first psychotic episode.
- Trial name
- NCT00188981
- Where
- Netherlands
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- UMC Utrecht